🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Systemic Light Chain Amyloidosis

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis NCT06699394NA2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teclistamab (Tec) Essen Amyloidosis Registry NCT06887283n/a1 site📍 Essen University Hospital, Essen Collection of Samples and Clinical Data From Patients With Amyloid Diseases NCT00898235n/a1 site📍 Boston Boston Medical Center · Tests: clonality analysis, polymerase chain reaction, protein analysis, biologic sample preservation procedure, laboratory bio… Rapid dFLC Response Predict CHR in AL Amyloidosis NCT06627309n/a8 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Dara IV, Bortezomib (drug), Dexamethasone, Cyclophosphamide (CTX), Dara SC Daratumumab for Patients With Light Chain Amyloidosis NCT06376214NA1 site📍 Nanjing Nanjing University School of Medicine · Tests: Dratumumab / Hyaluronidase Injection [Darzalex Faspro], Pomalidomide 4 MG, autologous stem cell transplantation (ASCT) BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis NCT07151690Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: anti-BCMA/CD3 bispecific antibody Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis NCT06342466Phase 21 site📍 Beijing Jin Lu, MD · Tests: Bortezomib, Pomalidomide, Dexamethasone Hungarian National Systemic Amyloidosis Registry NCT07689331n/a12 sites📍 Balatonfüred📍 Budapest📍 Budapest Semmelweis University The Italian Transthyretin Amyloidosis Web-Network NCT05444920n/a30 sites📍 Legnano📍 Orbassano📍 Ancona Fondazione IRCCS Policlinico San Matteo di Pavia A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis NCT05951816Phase 11 site📍 Knoxville University of Tennessee Graduate School of Medicine · Tests: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA) NCT07388602Phase 31 site📍 Beijing Sinocelltech Ltd. · Tests: SCTC21C, Bortezomib, Dexamethasone, Cyclophosphamide Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis NCT07335887Phase 23 sites📍 Beijing📍 Beijing📍 Xi'an Peking University People's Hospital · Tests: sonrotoclax, Daratumumab, Dexamethasone Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients NCT07266116Phase 1, Phase 227 sites📍 Beijing📍 Beijing📍 Chongqing Shanghai Chia Tai Tianqing Pharmaceutical Technology Develo… · Tests: TQB2934 injection A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) NCT06292780Phase 1, Phase 221 sites📍 Duarte📍 Denver📍 Boston Regeneron Pharmaceuticals · Tests: Linvoseltamab A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis NCT07215494NA1 site📍 Beijing Peking University First Hospital · Tests: First-Line Dara-BorCyD Treatment Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Optimize First-line Treatment for AL Amyloidosis With t (11; 14) NCT06192979NA7 sites📍 Beijing📍 Beijing📍 Beijing Jin Lu, MD · Tests: Daratumumab, Bortezomib, Dexamethasone, Venetoclax
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy